Silbersher
Silbersher v. Valeant Pharmaceuticals International, Inc
Opinion
trial_court Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 ZACHARY SILBERSHER, et al., Case No. 3:18-cv-01496-JD
8 Plaintiffs,
ORDER RE PERSONAL
9 v. JURISDICTION MOTION
10 VALEANT PHARMACEUTICALS Re: Dkt. No. 43 INTERNATIONAL, INC, et al., 11 Defendants.
12
13 Defendant Dr. Falk Pharma GmbH, a German corporation headquartered in Breisgau, 14 Germany, challenges personal jurisdiction in this District with respect to the Corrected First 15 Amended Complaint (“CFAC”) under the False Claims Act. Dkt. No. 43. A substantially more 16 detailed statement of the case will be provided in the order on defendants’ motion to dismiss for 17 failure to state a claim. Dkt. Nos. 36, 42. The parties’ familiarity with the record is assumed. 18 Falk’s motion to dismiss for lack of personal jurisdiction is denied. 19 Plaintiff-Relator Silbersher bears “the burden of establishing that jurisdiction is proper” in 20 response to Falk’s Rule 12(b)(2) motion. Boschetto v. Hansing, 539 F.3d 1011, 1015 (9th Cir. 21 2008). Where, as here, the Court has not required an…